What is nonsense?
The same argument can be said about checkpoint inhibitors just five years ago - "if anti-pd-1 treatments are effective, why aren't they being used." Now we know they are being tested in nearly every solid tumor type.
I laid out my rationale for electroporating checkpoint inhibitor (monoclonal antibody) DNA. Again, this doesn't mean the company is going to do that, it just seems like a logical next step from my perspective. And, because I know antibodies can be produced via electroporated DNA, it is also theoretically possible to achieve production of checkpoint inhibitors in-situ.